Vanda Pharmaceuticals Inc.VNDANASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
0.95
↓ 69% below average
Average (9y)
3.02
Historical baseline
Range
High:6.57
Low:0.60
CAGR
-12.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 0.95 | +57.9% |
| 2023 | 0.60 | -47.9% |
| 2022 | 1.15 | -62.8% |
| 2021 | 3.10 | +15.1% |
| 2020 | 2.69 | -27.4% |
| 2019 | 3.70 | -43.6% |
| 2018 | 6.57 | +68.7% |
| 2017 | 3.89 | -12.9% |
| 2016 | 4.47 | +43.4% |
| 2015 | 3.12 | - |